The clinical presentation and course of premenstrual symptoms

The Premenstrual Syndromes: PMS and PMDD

Volumn , Issue , 2007, Pages 55-62

  Freeman, Ellen W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856401201     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. Halbreich U, Borenstein J, Pearlstein T et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003; 28:1-23.
2. Andersch B, Wenderstam C, Hahn L et al. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 1986; 5:39-49.
3. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988; 33:340-6.
4. Wittchen HU, Becker E, Lieb R et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32:119-32.
5. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003; 6:203-9.
6. Cohen LS, Soares CN, Otto MW et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 2002; 70:125-32.
7. Sveindottir H, Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000; 79:405-13.
8. Angst J, Sellaro R, Merikangas KR et al. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 2001; 104:110-16.
9. Sveinsdottir H, Lundman B, Norberg A. Women’s perceptions of phenomena they label premenstrual tension: normal experiences reflecting ordinary behaviour. J Adv Nurs 1999; 30:916-25.
10. Steiner M, Pearlstein T, Cohen LS et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 2006; 15:57-69.
11. Bloch M, Schmidt PJ, Rubinow DR. Premenstrual syndrome: evidence for symptom stability across cycles. Am J Psychiatry 1997; 154:1741-6.
12. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 1999; 14:S27-33.
13. Eriksson E, Andersch B, Ho H-P et al. Premenstrual dysphoria: an illustrative example of how serotonin modulates sex-steroid-related behavior. CNS Spectr 2001; 6:141-9.
14. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 2003; 17:122-9.
15. Vickers K, McNally RJ. Is premenstrual dysphoria a variant of panic disorder? A review. Clin Psychol Rev 2004; 24:933-56.
16. Dimmock PW, Wyatt KM, Jones PW et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356:1131-6.
17. Wyatt KM, Dimmock PW, O’Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2002; 4:CD001396.
18. Endicott J, Amsterdam J, Eriksson E et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999; 8:663-79.
19. Pinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 2006; 186:362-72.
20. Freeman EW, Rickels K, Sondheimer SJ et al. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry 2004; 161:343-51.
21. Freeman EW, Rickels K, Sondheimer SJ et al. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 1999; 56:932-9.
22. Brown CS, Ling FW, Andersen RN et al. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994; 84:779-86.
23. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997; 33:303-9.
24. Pearlstein TB, Stone AB, Lund SA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 1997; 17:261-6.
25. Eriksson E, Hedberg A, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995; 12:167-76.
26. Taghavi E, Menkes DB, Howard RC et al. Premenstrual syndrome:a double-blind controlled trial of desipramine and metylscopolamine. Int Clin Psychopharmacol 1995; 10:119-22.
27. Yonkers KA, Barnett LK, Carmody T et al. Serial discontinuation of SSRI treatment for PMDD. Biol Psychiatry 1998; 43:1S-133S.
28. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55:332-5.
29. Elks ML. Open trial of fluoxetine therapy for premenstrual syndrome. South Med J 1993; 86:503-7.
30. Freeman EW, Sondheimer SJ, Rickels K et al. A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome. J Clin Psychopharmacol 2004; 24:351-3.
31. Brown WJ, Doran FM. Women’s health: consumer views for planning local health promotion and health care priorities. Aust N Z J Public Health 1996; 20:149-54.
32. Singh BB, Berman BM, Simpson RL et al. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 1998; 4:75-9.
33. Corney RH, Stanton R. A survey of 658 women who report symptoms of premenstrual syndrome. J Psychosom Res 1991; 35:471-82.
34. Campbell EM, Peterkin D, O’Grady K et al. Premenstrual symptoms in general practice patients: prevalence and treatment. J Reprod Med 1997; 42:637-46.
35. Freeman EW, Rickels K, Schweizer E et al. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 1995; 25:309-15.
36. Hurt SW, Schnurr PP, Severino SK et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992; 149:525-30.
37. Freeman EW, Sammel MD, Rinaudo PJ et al. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol 2004; 103:960-6.
38. Richards M, Rubinow DR, Daly RC et al. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 2006; 163:133-7.
39. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004; 161:2238-44.
40. WHO. International Classification of Diseases, 10th edn. Geneva:World Health Organization; 1996.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC. American Psychiatric Association; 1994.
42. American College of Obstetricians and Gynecologists (ACOG). Premenstrual Syndrome. Washington, DC: ACOG; 2000.
43. Smith MJ, Schmidt PJ, Rubinow DR. Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research. J Psychiatr Res 2003; 37:75-83.
44. Pearlstein T, Yonkers KA, Fayyad R et al. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 2005; 85:275-82.
45. Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res 1996; 65:97-106.
46. Meaden PM, Hartlage SA, Cook-Karr J. Timing and severity of symptoms associated with the menstrual cycle in a communitybased sample in the Midwestern United States. Psychiatry Res 2005; 134:27-36.
47. Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. J Psychosom Res 2002; 52:223-37.
48. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003; 6:203-9.
49. Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9:41-9.
50. Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J Reprod Med 2002; 47:279-89.
51. Steiner M, Streiner DL. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Can J Psychiatry 2005; 50:327-32.
52. Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 2004; 47:568-75.
53. Granella F, Sances G, Zanferrari C et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993; 33:385-9.
54. Martin VT, Wernke S, Mandell K et al. Symptoms of premenstrual syndrome and their association with migraine headache. Headache 2006; 46:125-37.
55. Granella F, Sances G, Allais G et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004; 24:707-16.
56. Kim DR, Gyulai L, Freeman EW et al. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 2004; 7:37-47.
57. Hsiao MC, Hsiao CC, Liu CY. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin Neurosci 2004; 58:186-90.
58. Kornstein SG, Harvey AT, Rush AJ et al. Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychol Med 2005; 35:683-92.